Pfizer, Hospira Beat FCA Suit Over Faulty Infusion Pumps

By Dani Kass (March 15, 2019, 5:34 PM EDT) -- Pfizer Inc. and its Hospira Inc. unit have beat a False Claims Act suit accusing them of silently fixing defects with infusion pumps without telling customers or the U.S. Food and Drug Administration, with an Illinois federal judge saying the whistleblower didn't specifically allege any Medicare fraud....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!